Professor Dr. Helga Rübsamen-Schaeff (CEO)

Position:

Chief Executive Officer (CEO)

Academic degrees:

PhD in Chemistry, Prof. of Biochemistry and Virology

Academic positions:

• Post-doctoral researcher at Cornell University Ithaca (USA) and University of Gießen, Group leader at the University of Cologne, two Sabbaticals at Harvard University (USA)
• Head of the Department of Immune Therapy followed by 7 years as Scientific and Managing Director of the Chemotherapeutic Research Institute Georg-Speyer-Haus in Frankfurt (Germany)
• Professor of Biochemistry and Virology at the University of Frankfurt

Industrial experience:

• Director of Antiviral Research, Bayer until 2001
• Senior Vice President and Global Head of Anti-Infective Research at Bayer HealthCare (Germany) until 2006

Memberships/ Supervisory Boards:

• Senator of the Fraunhofer Society until 2009
• Supervisory Council of the University Vienna
• Jury for the Innovation Price of the President of the State of Germany

Publications:

More than 180 original articles in international peer-reviewed journals and 120 reviews and/or book chapters

Patents and Applications:

In the areas of Oncology and HIV

Stipends/Awards:

• Stipend by the Studienstiftung des Deutschen Volkes
• Max-Kade-Stipend
• Karl-Winnacker-Prize
• Bundesverdienstkreuz Erster Klasse of the German State
• Mestemacher Prize „Manager of the Year 2004”